Cargando…
Prevention and Management of Bleeding Episodes in Patients with Acquired Hemophilia A
Acquired hemophilia A (AHA) is a rare autoimmune disease caused by autoantibodies inhibiting the function of coagulation factor VIII. It is characterized by spontaneous bleeding in patients with no previous family or personal history of bleeding. Although several large registries have collected clin...
Autor principal: | Knöbl, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294818/ https://www.ncbi.nlm.nih.gov/pubmed/30542801 http://dx.doi.org/10.1007/s40265-018-1027-y |
Ejemplares similares
-
Prevention and Management of Bleeding Episodes in Children with Hemophilia
por: Ljung, Rolf C. R.
Publicado: (2018) -
Management of Gastrointestinal Bleeding and Resumption of Oral Anticoagulant Therapy in Patients with Atrial Fibrillation: A Multidisciplinary Discussion
por: Martin, Anne-Céline, et al.
Publicado: (2023) -
CT-157 Another Rare Case of COVID-19 Vaccine Induced Acquired Hemophilia
por: Ismail, Asmaa M.
Publicado: (2022) -
Treatment of Community-Acquired Lower Respiratory Tract Infections during Pregnancy
por: Lim, Wei Shen, et al.
Publicado: (2012) -
Prevention of Chemotherapy-Induced Nausea and Vomiting in the Older Patient: Optimizing Outcomes
por: Herrstedt, Jørn, et al.
Publicado: (2021)